Atlas Trials

Lymphoma, Small Lymphocytic

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lymphoma, Small Lymphocytic

RecordFirmDate
Intermittent Fasting and CLL/SLL (NCT04626843)Eleah Stringer2021-02-03
Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL (NCT04342117)SecuraBio2020-04-23
Long-term Follow-up Study of Patients Receiving CAR-T Cells (NCT03375619)Medical College of Wisconsin2017-12-01
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) (NCT03331198)Juno Therapeutics, a Subsidiary of Celgene2017-11-27
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers (NCT02991638)The University of Hong Kong2016-11-01
Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (NCT02677948)University of Michigan Rogel Cancer Center2016-10-01
Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY) (NCT02292225)SecuraBio2015-02-01
Tandem Auto-Allo Transplant for Lymphoma (NCT01181271)Massachusetts General Hospital2010-08-01
A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL) (NCT01005979)Emory University2010-07-01
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas (NCT00783367)Abramson Cancer Center at Penn Medicine2008-07-01
EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00636155)David Rizzieri2008-02-01
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL (NCT00546793)Gilead Sciences2008-01-01
Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL) (NCT00290407)University of Louisville2006-03-01
Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00143065)Ohio State University Comprehensive Cancer Center2005-08-01
A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia (NCT00083473)Titan Pharmaceuticals2004-05-01
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma (NCT00060684)CTI BioPharma2001-12-01
A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma (NCT00081809)Agenus Inc.2000-03-01

Track Lymphoma, Small Lymphocytic automatically

Every clearance here is in the API, with alerts when new ones post.